ArticleBMC cancer2018

MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer.

San-Jian Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.